reference/2936803

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/2936803

Outgoing Links

Predicate	Object
contentType	Clinical Trial\|Clinical Trial, Phase II\|Journal Article\|Research Support, U.S. Gov't, P.H.S.
endingPage	277
issn	0277-3732
issueIdentifier	3
pageRange	273-277
publicationName	American Journal of Clinical Oncology: Cancer Clinical Trial
startingPage	273
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c286c8f1824f3bc0c7175bc5850ba5e1 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_abfcbbcf300cc059c6faf5e988895177 http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_40c5c922815a4b6958464975149a0975
bibliographicCitation	Kucuk O, Young ML, Habermann TM, Wolf BC, Jimeno J, Cassileth PA. Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study. Am J Clin Oncol. 2000 Jun;23(3):273–7. doi: 10.1097/00000421-200006000-00013. PMID: 10857892.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_690cdb4b03f31a718b5556e375d74f89 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ddf84fb6b22c923096f8d6fa6c9a50b7 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_42097415672dc0a8ba90e3d2c63ae81c http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_30fe942234e6c8419c75ac039b54d5c3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b5e11d5de60c5ef4e5e046d0091722eb http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d93b9c1e1f68771e3d62ea11879d93e1
date	200006
identifier	https://pubmed.ncbi.nlm.nih.gov/10857892 https://doi.org/10.1097/00000421-200006000-00013
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/413 https://portal.issn.org/resource/ISSN/0277-3732
language	English
source	https://www.crossref.org/ https://pubmed.ncbi.nlm.nih.gov/
title	Phase II trail of didemnin B in previously treated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group (ECOG) Study
discusses	http://id.nlm.nih.gov/mesh/M0458175 http://id.nlm.nih.gov/mesh/M0095381 http://id.nlm.nih.gov/mesh/M0016239 http://id.nlm.nih.gov/mesh/M0001483
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D047630 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D010456Q000009 http://id.nlm.nih.gov/mesh/D008228Q000188 http://id.nlm.nih.gov/mesh/D010456Q000627
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D012074 http://id.nlm.nih.gov/mesh/D007262 http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008228Q000473 http://id.nlm.nih.gov/mesh/D010456Q000008 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000970Q000008 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D008228Q000401 http://id.nlm.nih.gov/mesh/D008875
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID122651 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID550898 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID166640069 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8390 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5458707 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6711227 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID13895197 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8358 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID46173839 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID45280821 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID44298771 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID101598330 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID163341978

Showing number of triples: 1 to 64 of 64.